ADVANCED SEARCH
HOME
ABOUT US
AGENCIES
NEWS RELEASES
MULTIMEDIA
SPECIAL EVENTS
TOOLS
CONTACT
News Releases
Health & Medical
Translations:
All (English)
Chinese - Simplified
Chinese - Traditional
Hindi
Indonesian
Japanese
Korean
Malay
Pashto
Thai
Urdu
Vietnamese
Arabic
Bulgarian
Burmese
Canadian French
Czech
Danish
Dutch
Estonian
Finnish
French
German
Greek
Hebrew
Hungarian
Italian
Latvian
Lithuanian
Norwegian
Polish
Portuguese (European)
Portuguese (Latin American)
Russian
Slovakian
Spanish (European)
Spanish (Latin American)
Swedish
Turkish
Health & Medical Results: 1980 item(s)
INOVIO Announces Positive Data from Phase 2 Segment of Clinica...
- 10 May 2021 22:40
PLYMOUTH MEETING, Pa., May 10, 2021 /PRNewswire-AsiaNet/ -- -- INO-4800 was shown to be safe, well-tolerated and immunogenic in all age groups -- Phase 2 results informed INOVIO's selection of 2.0 mg dose for the Phase 3 segment of the trial -- Data published as a preprint in MedR...
COVID-19 has caused 6.9 million deaths globally, more than dou...
- 07 May 2021 01:00
SEATTLE, May 7, 2021 /PRNewswire-AsiaNet/ -- -- New analysis from IHME highlights the true toll of the pandemic Globally, COVID-19 has caused approximately 6.9 million deaths, more than double what official numbers show, according to a new analysis by the Institute for Health Metrics and ...
Novavax and Gavi Execute Advance Purchase Agreement for COVID-...
- 07 May 2021 00:16
GAITHERSBURG, Md., May 7, 2021 /PRNewswire-AsiaNet/ -- -- Novavax to deliver 350 million doses beginning Q3 2021 -- 1.1 billion doses of Novavax vaccine to be available to countries participating in COVAX -- Serum Institute of India to provide balance of doses for LMICs -- Underscores comm...
DarwinHealth Announces a Research Collaboration with Bristol M...
- 06 May 2021 22:53
NEW YORK, May 6, 2021 /PRNewswire-AsiaNet/ -- DarwinHealth, a New York City-based biotechnology company, today announced a scientific research collaboration with Bristol-Myers Squibb Company (NYSE: BMY). The research collaboration, the Novel Cancer Target Initiative (NCTI), employs quantitat...
Mirador unveils premium wrinkle-care skincare brand Le Mont Ch...
- 06 May 2021 20:56
GUANGZHOU, China, May 6, 2021 /PRNewswire-AsiaNet/ -- Mirador, the Chinese subsidiary of the Mirador Group, will unveil its premium wrinkle-care skincare brand Le Mont Charmant at the 2021 China Beauty Expo (CBE), Asia's pre-eminent skincare and cosmetics industry convention, with the aim of accelera...
Zero-Contact Medical Station for a Safe and Rapid PCR Covid-19...
- 06 May 2021 18:44
HSINCHU, May 6, 2021 /PRNewswire-AsiaNet/ -- Brain Navi Biotechnology Co., Ltd., a brain surgery robotic company, is launching "zero-contact" medical stations in hospitals across Taiwan, fully protect medical staff and patients from the cross-infection of "highly contagious diseases." The bi...
HeiQ launches high-tech mask featuring ground-breaking copper ...
- 05 May 2021 18:00
ZURICH, May 5, 2021 /PRNewswire-AsiaNet/ -- Global leader in textile and materials innovation, HeiQ, launches HeiQ MetalliQ, a futuristic-looking, high-tech surgical mask that destroys all viruses and bacteria tested, up to 100% efficacy. HeiQ MetalliQ doesn't only look metallic. The mas...
FDA Grants Donisi De Novo Clearance for Innovative Contact-Fre...
- 05 May 2021 11:00
TEL AVIV, Israel, May 5, 2021, /PRNewswire-AsiaNet/-- The U.S. Food and Drug Administration (FDA) has granted Donisi's [https://donisihealth.com/ ] revolutionary contact-free multiparameter measurement system de novo clearance, making Donisi [https://www.linkedin.com/company/donisihealth/ ] the first...
Sentinel Diagnostics Launches Two New Serological Tests To Qui...
- 04 May 2021 18:57
MILAN, May 4, 2021 /PRNewswire-AsiaNet/ -- To quickly assess the immune response to SARS-CoV-2 of patients and entire communities, Sentinel Diagnostics - an Italian company focused for more than 35 years on the development and production of In Vitro Diagnostics for the most advanced Clinic...
Metavention Announces Initiation of Groundbreaking Multi-Organ...
- 03 May 2021 23:00
MINNEAPOLIS, May 4, 2021 /PRNewswire-AsiaNet/ -- Metavention, Inc. announces the initiation of the MODUS Study (ACTRN12620000412932), to treat patients with both type 2 diabetes and hypertension using a catheter-based, minimally invasive approach. Logo - https://mma.prnewswire.com/media/15012...
Page 86 of 198
...
81
82
83
84
85
86
87
88
89
90
...
Go to page
All Categories
Automotive, Transport & Logistics
Business & Finance
Education
Energy, Mining & Resources
Environment
Events
General News
Health & Medical
Manufacturing
Media, Entertainment & Fashion
Property & Development
Retail & Hospitality
Science
Social Welfare
Sport
Technology & Innovation
Tourism & Leisure
Advanced Search
Search for either:
News Releases
Translations:
All (English)
Chinese - Simplified
Chinese - Traditional
Hindi
Indonesian
Japanese
Korean
Malay
Pashto
Thai
Urdu
Vietnamese
Arabic
Bulgarian
Burmese
Canadian French
Czech
Danish
Dutch
Estonian
Finnish
French
German
Greek
Hebrew
Hungarian
Italian
Latvian
Lithuanian
Norwegian
Polish
Portuguese (European)
Portuguese (Latin American)
Russian
Slovakian
Spanish (European)
Spanish (Latin American)
Swedish
Turkish
or
Multimedia
Type:
all
images
audio
video
mnr
other
Category:
All Categories
Automotive, Transport & Logistics
Business & Finance
Education
Energy, Mining & Resources
Environment
Events
General News
Health & Medical
Manufacturing
Media, Entertainment & Fashion
Property & Development
Retail & Hospitality
Science
Social Welfare
Sport
Technology & Innovation
Tourism & Leisure
Keywords:
Date range:
All
Range
From:
Open the calendar popup.
<<
<
September 2024
>
>>
M
T
W
T
F
S
S
35
26
27
28
29
30
31
1
36
2
3
4
5
6
7
8
37
9
10
11
12
13
14
15
38
16
17
18
19
20
21
22
39
23
24
25
26
27
28
29
40
30
1
2
3
4
5
6
To:
Open the calendar popup.
<<
<
September 2024
>
>>
M
T
W
T
F
S
S
35
26
27
28
29
30
31
1
36
2
3
4
5
6
7
8
37
9
10
11
12
13
14
15
38
16
17
18
19
20
21
22
39
23
24
25
26
27
28
29
40
30
1
2
3
4
5
6
Entries per page: